Comparison of a novel lateral-flow device to galactomannan assay at different time periods for detections of invasive aspergillosis

Diagnostic performance and longitudinal analysis of fungal biomarkers in COVID-19 associated pulmonary aspergillosis

“…Second, discrepant results were also reported previously. A study comparing GM-ELISA and GM-LFA in different periods for IPA showed that previous exposure to antibiotics could influence the lateral flow device results, leading to discrepancies in results [ 24 ]. Although we did not record antibiotic use in our patient population in the ICU, it is plausible to consider this factor might be effective.…”